Agile Robots

Agile Robots stands as one of the highest-valued intelligent robotics unicorns globally, with technology roots tracing directly to the German Aerospace Center (DLR). The company operates dual headquarters in Munich, Germany and Beijing, China, developing force-controlled robotic systems that serve applications across medical surgery assistance, rehabilitation therapy, and precision manufacturing.

Company Overview

Founded in 2018 by Dr. Zhaopeng Chen and a team of robotics experts from the DLR Robotics and Mechatronics Center, Agile Robots inherited decades of pioneering research in force-controlled robotics. The DLR was the first institution globally to conceptualize and successfully develop force-controlled robot series (LWR I through LWR IV), and this technological lineage forms the foundation of Agile Robots’ product portfolio.

The company achieved unicorn status in 2021 following a $220 million Series C round led by SoftBank Vision Fund 2, marking SoftBank’s largest intelligent robotics investment in China at that time. Additional investors include Sequoia Capital China, Hillhouse Capital, Xiaomi Group, Foxconn Industrial Internet, and Abu Dhabi’s Chimera Investments.

As of late 2025, Agile Robots has delivered over 30,000 robots to customers worldwide, with revenue reaching approximately €200 million and demonstrating consecutive year-over-year doubling for seven years.

Core Products

Diana 7 Med

The Diana 7 Med represents Agile Robots’ 7-degree-of-freedom medical-grade collaborative robotic arm. Each joint integrates high-precision torque sensors enabling force sensitivity down to 0.5N. This platform supports applications in orthopedic surgery, neurosurgery, laparoscopic procedures, gastrointestinal endoscopy, biopsy, ultrasound diagnostics, dental procedures, and rehabilitation therapy.

Rather than seeking independent medical device registration, Diana 7 Med serves as a core platform component for surgical robot manufacturers, enabling partners like Tinavi (orthopedic robots) and Remebot (neurosurgical robots) to build upon its force-control capabilities.

X-SPA Rehabilitation Robot

The X-SPA system targets physical therapy and wellness applications, incorporating the company’s force-control technology for massage and rehabilitation treatments. This solution has been deployed in partnership with leading tertiary hospitals in China for traditional Chinese medicine-style therapy automation.

Industrial Robot Lines

Beyond medical applications, Agile Robots produces the Thor series (3-20 kg payload collaborative robots), Diana 7 industrial arms, Autonomous Mobile Robots (AMRs), and the Agile Hand dexterous manipulator. In late 2025, the company unveiled Agile ONE, a humanoid robot scheduled for production at a new Bavarian facility in early 2026.

Technology & Innovation

Agile Robots’ technological differentiation centers on three pillars:

Force Control Precision: Proprietary algorithms combined with high-resolution torque sensors enable force sensitivity of 0.5N, allowing robots to perform tasks requiring human-like touch sensitivity such as delicate assembly and surgical assistance.

AgileCore Operating System: This AI-driven software platform provides rapid skill learning, enabling robots to acquire new operational capabilities through human demonstration rather than traditional programming.

Null-Space Control: Seven-degree-of-freedom redundancy with null-space control technology allows Diana 7 series robots to navigate around obstacles in confined workspaces, particularly valuable in surgical and manufacturing environments with spatial constraints.

The company holds extensive intellectual property across force sensing, motion planning, and human-robot collaboration domains. In 2023, Agile Robots won the iF Design Award for its Diana 3 robot and exhibition booth design.

Strategic Acquisitions

Agile Robots has pursued aggressive inorganic growth:

• 2023: Acquired Franka Emika (now Franka Robotics), a Munich-based pioneer in tactile robotics and the reference platform for academic robotics research
• 2024-2025: Acquired idealworks (BMW Group spin-off) specializing in automotive intralogistics robotics, and BÄR Automation for industrial system integration
• 2025: Acquired audEERING, a leader in AI voice recognition technology

Market Presence

The company serves global customers across automotive (BMW, Volkswagen), consumer electronics (Xiaomi, Foxconn), and healthcare sectors. Production facilities span over 15 sites worldwide, including a new Chennai facility serving India’s growing automation market.

In medical applications, Agile Robots maintains strategic partnerships with leading Chinese surgical robot companies including Tinavi (orthopedics) and Remebot (neurosurgery), supplying force-controlled arm platforms for integration into surgical systems.

Key Milestones

• 2018: Company founded with dual headquarters in Munich and Beijing
• 2019: Diana 7 industrial robot commercially launched
• 2020: Named highest-funded intelligent robot company globally; featured in Nature’s special issue on Chinese medical robotics
• 2021: Series C funding ($220M) led by SoftBank Vision Fund 2, achieving unicorn valuation
• 2023: Acquired Franka Emika; won iF Design Award; Kunshan (China) headquarters opened
• 2025: Revenue reached €200 million; cumulative robot deliveries exceeded 30,000 units; Agile ONE humanoid robot unveiled

Frequently Asked Questions

What medical applications does Agile Robots support?

Diana 7 Med supports orthopedic surgery, neurosurgery, laparoscopic procedures, endoscopy, biopsy guidance, ultrasound diagnostics, dental applications, and rehabilitation therapy. The platform primarily serves as an OEM component for surgical robot manufacturers rather than as a standalone medical device.

Is Agile Robots publicly traded?

Agile Robots remains privately held as of 2026. The company previously indicated IPO aspirations around 2024, though timing depends on valuation conditions and primary revenue geography.

How does Agile Robots’ technology differ from other collaborative robots?

The company’s core differentiation lies in force-control technology inherited from German Aerospace Center research. With joint torque sensors enabling 0.5N sensitivity, Diana 7 series robots can perform tasks requiring human-like touch sensitivity that conventional position-controlled robots cannot achieve.